BioLineRx (BLRX) Looks Good: Stock Moves 9.1% Higher – Tale of the Tape

March 25, 2015 Technicals 0

Zacks

BioLineRx, Ltd. (BLRX) was a big mover last session with its shares rising just over 9% on the day. The upside was owing to the company’s announcement of its financial results for the year ended Dec 31, 2014. This development led to far more shares changing hands yesterday than in a normal session. The move breaks the recent trend of the company as the stock is now trading above the volatile price range of $1.95 to $2.14 since March 6.

This clinical stage biopharmaceutical development company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

BioLineRx currently has a Zacks Rank #3 (Hold) and its Earnings ESP is 0.00%.

A better-ranked Med-Drugs stock is Lannett Company, Inc. (LCI) with a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply